Company G Medical Innovations Holdings Ltd OTC Markets

Equities

GMMVD

KYG394622081

End-of-day quote OTC Markets Other stock markets 06:00:00 2021-05-18 pm EDT			5-day change	1st Jan Change
5.05 ^USD	+1.00%		-.--%	-.--%

2023	G Medical Innovations Holdings Ltd announced that it has received $0.5 million in funding	CI
2023	G Medical Innovations Holdings Ltd announced that it expects to receive $0.5 million in funding	CI

Business Summary

G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.

Sales per Business

USD in Million	2021	Weight	2022	Weight	Delta
Patient Services 99.6 %	5	97.1 %	4	99.6 %	-10.32%
Products 0.4 %	0	1.0 %	0	0.4 %	-68.00%

Sales per region

USD in Million	2021	Weight	2022	Weight	Delta
Cayman Islands 100.0 %	5	100.0 %	4	100.0 %	-12.61%

Managers

Managers	Title	Age	Since
Yacov Geva CEO	Chief Executive Officer	73	14-10-02
Igor Bluvstein DFI	Director of Finance/CFO	44	22-07-30
Benny Tal CTO	Chief Tech/Sci/R&D Officer	54	17-11-30
Brett Tucker SEC	Corporate Secretary	-	20-02-04
Oded Shahar PRN	Corporate Officer/Principal	63	17-06-30

Members of the board

Members of the board	Title	Age	Since
Yacov Geva CEO	Chief Executive Officer	73	14-10-02
Kenneth Melani CHM	Chairman	70	14-08-20
Yehoshua Gleitman BRD	Director/Board Member	74	17-02-23
Urs Wettstein BRD	Director/Board Member	68	17-02-23
Chanan Epstein BRD	Director/Board Member	70	21-05-31
Zeev Rotstein BRD	Director/Board Member	73	19-03-04

Shareholders

Name	Equities	%	Valuation
Jonathan Rubini 28.42 %	73,856,931	28.42 %	901 055 $
Yacov Geva 0.7827 %	2,034,252	0.7827 %	24 818 $
Kenneth Melani 0.002265 %	5,888	0.002265 %	72 $
Oded Shahar 0.000876 %	2,276	0.000876 %	28 $
Zeev Rotstein 0.000766 %	1,990	0.000766 %	24 $
Yehoshua Gleitman 0.000720 %	1,872	0.000720 %	23 $
Urs Wettstein 0.000638 %	1,658	0.000638 %	20 $
Benny Tal 0.000635 %	1,650	0.000635 %	20 $
Dror Muriel Rot 0.000611 %	1,587	0.000611 %	19 $
Chanan Epstein 0.000079 %	206	0.000079 %	3 $